+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07361224

Safety Study of CLS-015 Combined With Anti-CD19 CAR-T Therapy for Adults With Stable or Progressive Large B-Cell Lymphoma at Lymphodepletion

Led by Tel-Aviv Sourasky Medical Center · Updated on 2026-05-01

12

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety of a combination treatment using CLS-015 with anti-CD19 CAR-T cell therapy in patients with large B-cell lymphoma who have stable or progressive disease during lymphodepletion. This Phase 1, single-center, open-label study aims to improve clinical response by reversing negative effects of neutrophil extracellular traps NETs on immune function and CAR-T cells, addressing the high risk of early disease progression in these patients. Participants will receive CLS-015 as an intravenous infusion on days 0, 3, 6, 10, and 15 after the CAR-T cell infusion. CLS-015 is being studied for its potential to enhance CAR-T cell activity, prevent T-cell exhaustion, reduce cytokine release syndrome, and improve CAR-T penetration into lymphoma areas by enzymatically breaking down NETs. All enrolled patients with stable or progressive disease during lymphodepletion will receive this treatment schedule. During the study, participants will be closely monitored with blood tests and evaluations for cytokine release syndrome, neurotoxicity, HLH-like syndrome, and cytopenias. Follow-up visits occur daily for 15 days after CAR-T infusion, then twice weekly for another 15 days, with additional checkups at 2, 6, 9, and 12 months post-infusion. The study will assess safety and tolerability over an average of two years from treatment start.

CONDITIONS

Brief Title

Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.

Research Team

R

Ron Ram, Prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here